Divergences in antihypertensive therapy in special situations in nephrology
CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Paulista de Medicina
|
Series: | São Paulo Medical Journal |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=en |
id |
doaj-23e710b7986340a8bc096216bd2377bd |
---|---|
record_format |
Article |
spelling |
doaj-23e710b7986340a8bc096216bd2377bd2020-11-25T01:51:51ZengAssociação Paulista de MedicinaSão Paulo Medical Journal1806-94601261344010.1590/S1516-31802008000100007S1516-31802008000100007Divergences in antihypertensive therapy in special situations in nephrologyMarcelo Montebello Lemos0Alessandra Coelho Pedrosa1Alze Pereira Tavares2Miguel Ângelo Góes3Sérgio Antônio Draibe4Ricardo Sesso5Universidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloCONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=enHypertensionAntihypertensive agentsKidney diseasesGuidelinesEvidence-based medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marcelo Montebello Lemos Alessandra Coelho Pedrosa Alze Pereira Tavares Miguel Ângelo Góes Sérgio Antônio Draibe Ricardo Sesso |
spellingShingle |
Marcelo Montebello Lemos Alessandra Coelho Pedrosa Alze Pereira Tavares Miguel Ângelo Góes Sérgio Antônio Draibe Ricardo Sesso Divergences in antihypertensive therapy in special situations in nephrology São Paulo Medical Journal Hypertension Antihypertensive agents Kidney diseases Guidelines Evidence-based medicine |
author_facet |
Marcelo Montebello Lemos Alessandra Coelho Pedrosa Alze Pereira Tavares Miguel Ângelo Góes Sérgio Antônio Draibe Ricardo Sesso |
author_sort |
Marcelo Montebello Lemos |
title |
Divergences in antihypertensive therapy in special situations in nephrology |
title_short |
Divergences in antihypertensive therapy in special situations in nephrology |
title_full |
Divergences in antihypertensive therapy in special situations in nephrology |
title_fullStr |
Divergences in antihypertensive therapy in special situations in nephrology |
title_full_unstemmed |
Divergences in antihypertensive therapy in special situations in nephrology |
title_sort |
divergences in antihypertensive therapy in special situations in nephrology |
publisher |
Associação Paulista de Medicina |
series |
São Paulo Medical Journal |
issn |
1806-9460 |
description |
CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence. |
topic |
Hypertension Antihypertensive agents Kidney diseases Guidelines Evidence-based medicine |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=en |
work_keys_str_mv |
AT marcelomontebellolemos divergencesinantihypertensivetherapyinspecialsituationsinnephrology AT alessandracoelhopedrosa divergencesinantihypertensivetherapyinspecialsituationsinnephrology AT alzepereiratavares divergencesinantihypertensivetherapyinspecialsituationsinnephrology AT miguelangelogoes divergencesinantihypertensivetherapyinspecialsituationsinnephrology AT sergioantoniodraibe divergencesinantihypertensivetherapyinspecialsituationsinnephrology AT ricardosesso divergencesinantihypertensivetherapyinspecialsituationsinnephrology |
_version_ |
1724995998897405952 |